From: Clinical trial of extended-dose chloroquine for treatment of resistant falciparum malaria among Afghan refugees in Pakistan
Days after treatment start
Odds ratio (95% CI)
p-value
7
0.20 (0.05, 0.73)
0.02
14
0.18 (0.08, 0.40)
< 0.0001
21
0.15 (0.07, 0.31)
28
0.18 (0.09-0.38)
35
0.18 (0.08, 0.39)